Methods and Systems for Diagnosing and Treating Fibromyalgia
Summary
The USPTO granted Patent US12588828B2 to inventor Robert S. Katz, covering methods and systems for diagnosing and treating fibromyalgia using pressure measurements from saline injection into muscle locations. The patent protects a device comprising a needle, saline-filled syringe, connecting tube, and pressure sensor. The patent contains 12 claims.
What changed
The USPTO issued Patent US12588828B2 on March 31, 2026, to inventor Robert S. Katz. The patent covers methods for diagnosing fibromyalgia by inserting a needle at a patient location, injecting saline solution, and measuring pressure against a threshold value to determine diagnosis. The device claims include a needle, syringe with saline solution, tube positioned between the syringe and needle, and a pressure sensor configured to obtain pressure values at muscle locations. The patent application was filed on June 14, 2021, under application number 17346741.
Medical device manufacturers developing pressure measurement devices for muscle diagnostics should review this patent to understand potential infringement implications for competing technologies. Healthcare providers should be aware of this novel diagnostic methodology for fibromyalgia, which may offer improved diagnostic capabilities compared to existing techniques. No immediate compliance actions are required.
Archived snapshot
Mar 31, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Methods and systems for diagnosing and treating fibromyalgia
Grant US12588828B2 Kind: B2 Mar 31, 2026
Inventors
Robert S. Katz
Abstract
The present disclosure provides methods and systems for diagnosing and treating fibromyalgia in a patient. In one method, a pressure value is obtained for the patient, wherein the pressure value is determined by inserting a needle of a device into a location in the patient, injecting saline solution into the patient at the location, and measuring a pressure at the location; and fibromyalgia is diagnosed in the patient if the pressure at the location exceeds a threshold pressure value. The present disclosure also provides a device for use in the methods of the disclosure. One such device includes a needle, a syringe including a saline solution, a tube positioned between the syringe and the needle, and a pressure sensor configured to obtain a pressure value at a muscle location of a patient.
CPC Classifications
A61B 5/03 A61B 5/1107 A61B 5/224 A61B 5/4519 A61B 5/4839
Filing Date
2021-06-14
Application No.
17346741
Claims
12
Related changes
Get daily alerts for USPTO Patent Grants - Diagnosis & Surgery (A61B)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Diagnosis & Surgery (A61B) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.